
- 积分
- 3
- 威望
- 3
- 包包
- 20
|
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸
5 R( \6 B2 m( t# j7 m+ k' d2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷
+ t* t' G+ M8 C4 v1 x6 I' F3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷
# k0 h- h- R) o) D5-Aza:5-azacytidine,5-氮(杂)胞苷
# X5 y# n# m, Y4 c' `a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
- x2 S& K0 k0 D2 z* `8 V" HAA:aplastic anemia,再生障碍性贫血
# J* d# Y+ [+ o7 Y9 ]5 R) l( C. VAAV:adeno-associated virus,腺病毒相关病毒
! t+ O% P6 ^. y- [Ab:antibody,抗体! N4 U+ D1 \) k" J' [
ABC:avidin-biiotin complex method, 亲和素生物素复合物法
9 ~- o) I: T# n- a1 ~' h; yABMT:autologous bone marrow transplant,自体骨髓移植
% M2 p0 U1 E2 oAc:accessory cell,辅佐细胞3 E' d: _4 M8 m3 f D. _, C. b3 f
ACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
, A4 k2 e( R) w/ w. M o4 n+ z0 qACP:acid phosphatase,酸性磷酸梅) `% X0 s n7 I. B) p6 P T6 M
ACTD:actinomycin D,放线菌素D( `6 l8 U# w4 `7 d$ ]( \; a, _
Acute:急性的 " C7 B w3 y, e8 H' v
ACV:cyclovir,阿昔洛韦
4 j% g0 R* _. d4 c! ]! t/ e* kAd:adenovirus,腺病毒$ d* S( F2 W6 D
AD:antigen determinant,抗原决定簇9 g- I( |: u3 U
ADA:adenosine deaminase,腺苷脱氨酶- K& i- `+ z, G( e) }! O
ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性- j; k* l8 D+ k3 p! g; Q% F
Adjuvant therapy:辅助治疗
7 k: t% ^5 d+ c+ L8 q. ^AEL:acute erythrocytic leukemia,急性红白血病2 L, u; v `$ u; [. [
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病2 y: W! @4 X, p* \
AFP:alpha fetoprotein,甲胎蛋白
" X% m2 j! f5 q2 I8 C/ sAg:antigen,抗原# }* b9 a; X5 G9 x8 Y
aGVHD:acute graft versus host disease,急性移植物抗宿主病$ H- z8 }9 f( h: g3 A' n/ j( g. j
Aid:anti-idiotype antibody,抗独特型抗体$ R. D. P; s/ R
AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征1 C8 R8 v, v8 ?
AIF:apoptosis-inducing factor,凋亡诱导因子5 N; F# ?6 ^" Z+ a
AIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血7 O6 f8 J5 H1 I1 h
AL:acute leukemia, 急性白血病* i" q. U( T$ \! B) k
ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
- ?: M8 g7 F- GALG:antilymphocyte globulin, 抗淋巴细胞球蛋白# \! C3 s) Y& t/ Z) o) R# D. o
ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
! {3 r! D& M+ L3 Y8 ~. bALL:acute lymphocytic leukemia,急性淋巴细胞白血病
: K) f, [% M9 v8 uAllo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植
% B; R3 `2 {% {# w% pAllo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
! k/ X7 l: N5 [7 y5 kAllogeneic:异基因的 3 s! w/ `8 I0 l+ \/ e* B$ i% I- O
Allograft:异体移植物
|3 O$ d$ o5 |& LAlopecia:脱发6 i# {- k! K7 R q K' D/ d
ALP(AKP):Alkaline phosphatase,碱性磷酸酶
# K8 R# C8 O- a, WAM:adhesion molecule,粘附分子4 B0 }: G1 G9 T% [& O
AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病" c7 g ~' R+ X" z
AML:acute myeloid leukemia,急性髓性白血病
; c# n& |2 c" N F% b. {* n, _5 x+ pAMM:agnogenic myeloid metaplasia,特发性髓外化生
% q* B* ~) ?" H/ a" i; pANA:antinuclear antibody,抗核抗体
# V% Q) }. a1 m, l0 R8 {. `: rAna-LL:anaplastic large cell lymphoma,大细胞淋巴瘤* T3 s7 u7 E" H* l# a% e I# v
Anaphylaxis:过敏症! B4 s8 J! N8 J+ r
+ C6 p( ]8 d7 {2 ^# j
ANC:absolute neutrophil count,中性粒细胞绝对值
* p# @4 z5 c9 m6 `% BAnemia:贫血
4 m/ |1 N& \9 h7 \6 _ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
9 Q: i# O U& v# x7 {5 r6 [Antibiotic:抗生素;抗生的 5 {9 p) c% G+ S: K" G( l1 B
Antiemetic:止吐剂,止吐药 ) a) l- z2 H l6 o2 f7 r- w
antineoplastic drugs:抗肿瘤药物; A8 r. H8 j, y$ a m
Antisense:反义引物+ `# F& `& g# z% Q j& d
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植+ j+ D) m( B3 t/ a3 X/ G" q
APC:antigen processing cell,抗原呈递细胞1 m+ [0 `4 t U' g& b- D" h+ c+ J2 e
Apheresis:血浆分离置换法,血液成分部分清除 : ^* m0 e3 g0 C1 a; {. N$ F; `
APL:acute promyelocytic leukemia,急性早幼粒细胞白血病
. @, R; s3 s- i& Y5 b6 Q9 p3 vAplasia:发育不良,成形不完全
4 Z" { x7 Y) [0 ~ y+ z7 u0 r$ wApoptosis:凋亡
$ p8 d0 v! b, P/ x( fAra-C:arabinosyl cytosine,aracytidine阿糖胞苷. X) }" n' E, }! K% V
ARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病! z+ l6 o6 B$ u" \9 A
Ascites:腹水
( C7 r+ P. n! @, V& i6 V2 aASCT:autologous stem cell transplantation,自体干细胞移植+ _- A0 S3 e7 g- [/ _! u0 @: t
Aspergillus:曲霉属& l3 \' N9 A# a+ q7 ^ F" ?
ASS:anterior superior spine,髂前上棘9 Z# S4 ?' k- [0 p$ e/ b
AT1257:nitrocaphane,消瘤芥
: Z* r- x9 L% RATG:antithymocyte globulin,抗胸腺细胞球蛋白$ w& U3 {6 w) Z8 V
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤& I' l% [7 y2 G
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征
6 l3 t. T$ Z. w0 R3 V r" f# BATRA:all-transretinoic acid,全反式维甲酸
3 z. M* \( l, m$ h, Z3 o$ ?8 M2 ZAUL:acute undifferentiated cell leukemia,急性未分化细胞白血病" t# b4 n5 V5 {8 |4 i
AuSCT: autologous stem cell transplantation,自体造血干细胞移植
. C3 O: l, k7 XAutologous:自体的
) Y% A( t @" TAutograft:自体移植物 % o8 v* i6 I# C# u1 q9 n/ J' O% ^
Auto-BMT: autologous bone marrow transplantation,自体骨髓移植
3 O! G) v$ u- A: M: l# J" J% p4 }β2-MG:β2-microglobulin,β2-微球蛋白
0 J; B2 J6 Q2 ~0 BBack-up:备份6 _1 G" o* k* _, s9 w8 ]' o& C
BCNU:Carmustine,卡氮芥,卡莫司汀2 }* s, ^1 _6 k% c
BCR:breakpoint cluster region,断裂点丛集区
+ `, C7 D# H% \& gBFU-E: burst-forming unit-erythroid,早期红系集落生成细胞
5 b- s x1 G) j0 `. S1 M( ~Biopsy:活检 ) t' w1 m( r2 v* a$ ^
Blast cell:原始血细胞,母细胞
& A& h1 ~* _2 [- n; C$ x$ S" Q2 aBlast-CFC:blast colony forming cell,原始细胞集落形成细胞% L i% L" O- E: I& L4 Z& U; p
Blast crisis:原始细胞危象
# f* h0 C9 x; f T# V UBm:memory B lymphocyte,记忆B淋巴细胞
" o& L# t7 r: J) a, k$ ^8 qBMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病
/ f( F3 s2 n7 H. ^ a8 KBMT:bone marrow transplantation,骨髓移植
* C8 x7 n1 t |$ U$ \Bone marrow biopsy:骨髓活检# X7 i2 y9 p" W& @# W# u! M# v' X
Bone marrow puncture:骨髓穿刺* ]( z$ E6 Y2 Y2 o( _
Bone marrow smear:骨髓穿刺涂片7 D4 r0 r8 J# M! n6 d
BRM:biological response modifier,生物应答调节剂7 c/ T* }3 v9 W
Bu:busulfan,白消安,马利兰 # p b: j: G i& P+ Q( F' a
Buffer:缓冲,缓冲剂,缓冲液0 ^5 b7 b7 o6 ~/ y9 A: `& F g7 X
CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原- r# B0 C/ l* a- J/ S
CAM:cell adhesion molecule,细胞粘附分子
& z6 [, q, y/ H; Q& z: ]; m) _/ mCandida:念珠菌属,假丝酵母属
: l/ K8 [1 ~- Z: f$ P: ICatheter:导管 : r7 l) l, Z( H( w2 T2 ^5 q
CB:cord blood,脐带血& C* [; X0 [# x- J; f" m
CB1348:chlorambucil:苯丁酸氮芥
: J3 {' ]+ K+ k3 q1 h& V7 x- `CBC:complete blood count,全血细胞计数 5 Q& B3 F) a* f4 j, p. T
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
& Z' s1 A5 Q9 N" bCBSCT:cord blood stem cell transplantation,脐血干细胞移植
7 F1 l* h I+ Y( Y; hCCI:corrected count increment,校正增值计数) D+ d/ R7 v( u% U( ?+ [8 c
CCNSA:cell cycle non-specific agents,细胞周期非特异性药物
3 [9 r6 ~3 M. l7 T; @CCNU:lomustine,洛莫司汀,环己亚硝脲
0 Q' C, | G) P1 ]CCR:continuous complete remission,持续完全缓解' ^5 F& a5 R4 j0 W
CCSA:cell cycle specific agents,细胞周期特异性药物
0 b/ Y( \, B9 j* e5 GCD:Castleman's disease,Castleman病$ C. ?0 }' D! g( _5 v- p n' m
CD:cluster of differentiation,分化群* Y% g% ~4 d% K7 v# Y: M1 q* {, ^
CD3AK:CD3 activated killer,CD3激活的杀伤细胞+ A) u" G( d- E1 w6 u* V& R6 W6 d7 R' S
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶5 ~) T" \3 l: m2 E
CEA:carcinoembryonic antigen,癌胚抗原0 Z- ?& q& X5 _
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
( U5 M2 z" r; C8 l- v5 r/ y2 ?* @Central line:中心静脉导管,见central venous catheter.
7 I! E( [# t; k* V1 HCentral venous catheter: 中心静脉导管,又叫做central line,Hickman catheter
. w% N! {/ j5 i2 A. b: ^* z, NCentrifugation:离心
8 [! v6 x3 x, b8 bCFC:colony-forming cell,克隆形成细胞
5 \- f+ r" u1 m9 U0 GCFU:colony-forming unit,集落形成单位( P C- M* @ T& u
CFU-Blast:colony-forming unit-Blast,原始集落生成细胞
2 P$ Z' [- E- [) h, D' pCFU-E:colony-forming unit-erythroid,红系集落生成细胞; y% K" ] R0 z) ^' u
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞! a7 q z8 g8 c$ n) B
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞
; x* {+ Y! n" B9 K! VCFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
8 b% B+ k1 l& u3 @* ]CFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
0 a5 d5 ]& U i1 p- SCGD:chronic granulomatous disease,慢性肉芽肿病
. f9 e- I a# ], D: X* HCGP:circulating granulocyte pool,循环粒细胞池
4 q/ ~' r7 M& M) o; p& `# tcGVHD:chronic graft versus host disease,慢性移植物抗宿主病: Z5 x, b* M' ?
Chemo-responsive:化疗敏感的 ' I; Z- p) ?! a9 H/ }- P
Chemotherapy:化学疗法 ; y4 J% g' u9 o9 W9 C7 l% `7 X
Chronic慢性的 7 C9 p- ^$ \: f7 L: M" a+ G; I6 d# X
C.I.:continuous infusion,持续静脉点滴0 K. y+ h1 F' i t1 F
CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞
+ U G4 { n3 L$ }* B xCliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统; Q* N, n. ^) g" `3 w
CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病: w" q& G1 C) h5 w+ G
CML:chronic myelogenous leukemia,慢性粒细胞白血病' c7 z( n: d- ^3 `2 h* P1 s" W
CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期) x% G6 \& F2 X
CML-BP:CML-blastic phase,慢性粒细胞白血病急变期! ]5 K3 {6 Y9 B7 \$ W+ i
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
+ K0 r8 A' C0 o; OCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病
6 ^5 r& \# c( oCMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病0 G+ @. E* z/ |3 F# r. E0 o" S' w/ ?2 W3 f
CMV:cytomegalovirus,巨细胞病毒
9 T# y- Z l; b& R# ECNR:cytokine negative response cell,细胞因子不反应细胞
- i, m, a ~+ X6 Z# J( D5 c+ l7 k+ pCNS:central nervous system,中枢神经系统
8 ]& ^! o1 _5 ` c( iCNSL:central nervous system leukemia,中枢神经系统白血病
/ R" n$ r9 v: B5 F. ^1 D5 @) lCollection: 采集
$ e; j: N% ~7 d, B9 ^) B( J( \Colony stimulating factor:集落刺激因子
3 G3 w: g3 f+ I- pc-onc:cellular oncogene,细胞癌基因5 ~9 D6 Q1 H9 ]+ x; P+ |: K& p7 L
Conditioning:预处理
. C B0 h6 T/ d6 R. g8 Q% w" CConjunctivitis:结膜炎 T! B% ]6 P( b5 z& o7 v
Convalescence:恢复,恢复期# n) i/ S7 i a( d ?
CP:cancer procoagulant,癌性促凝物质9 \" U- ~$ _, u0 m/ w( X' k [/ ~1 f
CPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖6 O; Y/ a: e" e; T
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤6 @8 ~% R( Z1 k x
Cpmax:peak concentration,峰浓度
6 d9 K9 I4 }* R0 }. D) y5 lCPT:camptothecine,喜树碱
5 d+ O: m: f/ O! [CR:complete remission,完全缓解
b$ @+ k2 A" d7 f% b( @: b3 G# oCRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
, v4 i# R: ^% N# \2 cCRP:C reaction protein,丙反应蛋白 " N) H. d; p; c+ [! ~- [
CRR:complete remission rate,完全缓解率
0 L% ^. H( x+ W. zCryopreservation:冷冻保存,深低温保藏
~& l9 Z1 a7 z3 V$ v1 `1 ECSF:colony stimulating factor,集落刺激因子
/ ^7 d: `( w6 ICSF:cerebrospinal fluid,脑脊液
3 U5 H$ B6 p i9 O* aCTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
6 i; J0 V7 D9 F" T8 K( ACTCL:central T cell lymphoma,中枢T细胞淋巴瘤
' F; X9 N w' v% S# [CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞, m! b7 E8 @& Y! P8 T
Cyclin:周期素) i4 y3 }0 ]% P
Cytomegalovirus:巨细胞病毒 # L8 w# Z) ^9 P; u
DC:dendric cell,树突细胞
- T+ j: L; a+ b2 A3 pD-D:D dimer,D-二聚体: q6 J3 i0 M- G2 ^ L
Del:deletion,缺失
+ r. ~/ f+ s" P/ n+ n4 [( ~Dermatitis:皮炎
9 B3 y' }7 ]. E9 I+ Q2 g; F' [De nova AML:非继发性急性髓性白血病 ) [- i+ R# t" @; [( A4 F
DFS:disease free survival,无病生存期
7 R& T) I, `5 t! A( x. f3 rDI:DNA index,DNA 指数
& O$ s) ~- k" s/ v5 HDIC:disseminated intravascular coagulation,播散性血管内凝血: [! | P6 w5 t6 B+ ?: ]! T
Dilution:稀释; R E; Z- \1 O1 D; m) d6 e8 j
DL:discordant lymphoma,混杂型淋巴瘤
3 G5 m; M4 T' q; U1 f& uDonor:供者9 ~- v/ {+ o- _: \
Dysplasia:发育不良,发育异常
/ R# }3 w& @1 b( `8 [EBV:Epstein-Barr virus,EB病毒$ h8 j5 U/ O8 o0 N% G' w. C' K
ECM:extracellular matrix,细胞外基质. @7 e( Q2 m7 b7 ^- j* n
-ectomy:(后缀)(外科)切除,除去,去掉
/ O& f# F/ a l1 e0 d6 S# VEdema:水肿 0 J- b% q+ p/ ?9 n) |- Q- y
EGF:epithelial growth factor,表皮生长因子
- l1 Q; u6 S- v-emia:(后缀)血液疾病 ! H' B: f% \0 q. Y
Encephalopathy:脑病
0 f$ y! \* q8 G% JEncode: 编码
6 N- Q8 a; z" X/ u) x. G/ uEngraftment:移植物植入
3 a( o: q9 f; t" w3 JEnrich:富集. ~- I' U7 H9 U3 }% f8 T3 `0 o
Enzyme:酶 ; E! G- D& p- N' y! l
Eosinophil:嗜酸性粒细胞
+ {9 _ f" I/ i h# m! L2 XEPO:erythropoietin,促红素,红细胞生成素* o3 w) A0 V# E. b, n& Z) r. U
ETT:essential thrombocythemia,原发性血小板增多症, U. r7 E& ?2 N
Ex vivo:体外 3 c5 T- n! w) ~/ ~3 }, F
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统
; P6 v. p- d4 p- M. d1 RFCM:flow cytometry,流式细胞分析技术
( A% j9 F: B4 xFDC:follicular dendritic cells,滤泡树突状细胞
. {/ _4 g) |- s2 gFDGF:fibroblast derived growth factor,成纤维细胞源生长因子 % D. U, ^! M) a& m/ U
Febrile:发热的
9 ~3 e- [! [9 lFFP:fresh frozen plasma,新鲜冰冻血浆
1 R4 D% \" K& A# H: RFGF:fibroblast growth factor,成纤维细胞生长因子
* J% U. d6 A( l& }" i6 t7 u bFHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症
/ L$ b* |' `4 L/ \* LFISH:fluorescence in situ hybridization,荧光原位杂交$ ?! P8 X. }7 t' M: y
FMF:familial Mediteranean fever,家族性地中海热
" R: |: N6 D B% [Foley catheter:弗利氏导尿管,气囊导尿管
8 t# g. i" J' hFrTBI:fractional total body irradiation,分次全身照射9 A# {8 b- L- L* @6 }
FSRC: 胎羊体内增殖的人造血干细胞" l$ j5 A$ h/ a" y0 P5 i% L
Fungus:真菌
( m5 R( i# v" {5 I2 MFungi: Fungus复数形式/ C* k" ?) p7 X! \( g
G6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶; h1 I" g: r( z
Gastritis:胃炎
0 ~8 ^4 Z4 ]# u2 ^Gastrointestinal:胃肠道的 / I0 N0 D6 T" _4 R- \
G-CFC:granulocyte colony forming cells,粒细胞集落形成细胞; y% o$ e8 Q7 q' x! e
G-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
+ X1 B4 F" a. SGCV:cytomegalovirus,巨细胞病毒+ u7 _: K% l8 e7 t" t4 e9 G/ z2 |: V
GCV:ganciclovir,更昔洛韦
( P! q0 y! p: n6 }3 h3 R; XGI:gastrointestinal,胃肠道的7 P* x% K C! J ?
GM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子
2 j$ i7 V# y, M- }, pGM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
. X+ ~) Y: U, j {+ rGraft rejection:移植排斥(反应) 4 X- r& r! e, s6 j1 m
Graft-versus-host disease:移植物抗宿主病
' T3 o) W% N3 r/ ~Granulocyte:粒细胞 9 @4 D8 L1 L8 m( @
Growth factor:生长因子
& q4 G. C. u) r9 tGTR:granulocyte turnover rate,粒细胞转换率 C$ K5 o/ R8 c7 o6 t( m$ i# D
GVHD:graft-versus-host disease,移植物抗宿主病
: R3 D2 z, Q) N1 d% G7 r+ LGVHR: graft-versus-host reaction,移植物抗宿主反应
6 A' W, d1 u# R* e0 w3 TGVL:graft-versus-leukemia,移植物抗白血病
& K) B1 v/ }. ^ V: [8 f- IGVT:graft-versus-tumor,移植物抗肿瘤+ R& S; O2 X% z2 N- {0 g$ F
Haploidentical: 半相和的* a. V$ K! q O0 i
Harvest: 收集,采集7 b v: P# ?( I1 n- B) O
HC:hemorrhagic cystitis,出血性膀胱炎2 h k- `, z+ k4 D
HCL:hairy cell leukemia,毛细胞白血病
/ t% x& S" P, y% F4 DHD:Hodgkin's disease,霍奇金病3 ~+ M1 C9 X" f' {
HD:high dose,大剂量
7 [; | R- Y6 h( vHematocrit:红细胞压积 - }4 G" S& f' y. u, P
Hematology:血液学 % m( |, o+ f' h* j1 w. [ \$ [7 ]
Hematopoiesis:造血作用,生血作用. i- v) K1 n N, h
Hematopoietic system:造血系统4 O7 ]& V) f) y0 f9 {5 W- s# }
Hemoglobin:血色素,血红蛋白 : D- L( e4 i$ D: k
Hemorrhage:出血 ' n# C* A7 f( {$ O
Hemorrhagic cystitis:出血性膀胱炎
4 R# C* M$ r, vHepat - :(前缀)肝的
6 U4 a' l! Y, ~Hepatitis:肝炎 6 v* W6 d9 H2 v$ r" C$ {2 p, B( J
HES:hypereosinophilic syndrome,高嗜酸粒细胞综合征
) r6 O( j( v2 L3 mHGF:hematopoietic growth factor,造血生长因子0 Q* s- Y c, R' r" l; L" O- I
HHV:human herpus virus,人疱疹病毒- P) o; U& J) @7 d+ o/ a" S5 s. |
Hickman catheter:Hichman导管,中心静脉插管 ; H6 G: Q0 D- o0 }0 L
HIV:human immune deficiency virus,人免疫缺陷病毒
8 Z$ z" b0 z X8 W" mHLA:human leukocyte antigen,人类白细胞抗原 ( K; Y! M) K) O6 W
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
/ s a; B7 Q/ M; ^8 V& X4 wHMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症" l3 R; J% M* T& W
Homogenic transplantation:同基因移植: M7 P, V. P: F# H
Homozygote:纯合子# B" c( o5 f. w% d: ^
HPC:hematopoietic progenitor cell,造血祖细胞
6 T) z0 M( @& r a) P3 f/ C8 }HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位
2 K* t, r% O i$ ~) o0 W' J# sHR-ALL:high risk ALL,高危型急性淋巴细胞白血病
% z" C7 `# `* N/ Q9 I! W; @HSC:Hand-Schuller-Christian disease,韩-薛-柯病0 i4 u! y6 b4 I/ u- Z
HSC:hematopoietic stem cell,造血干细胞
! H8 l/ F0 R' z( A; E) }% {HSR:homogenously staining region,均染色区
- v" d# `2 D7 DHSV:herpes simplex virus,单纯疱疹病毒# [) }4 ?9 T- a( W! R# @# Z4 V. U1 {+ P
HTC: typing cell,纯合子分型细胞
: \- J3 E. p& R8 ^) m) mHTLV:human T cell leukemia virus,人类T细胞白血病病毒4 X! U# O+ u/ v5 V
HVOD:hepatic venous occlusive disease,肝静脉闭塞病
! _ g% h: P' j6 k9 @, |3 gHyper- :(前缀)高,超,(过)多) C- O- x7 N2 ~. h4 ^& v& L
Hyperalimentation:高营养支持,静脉高营养 f3 n+ ~) l( N1 U5 Q) S
Hyperpigmentation:色素沉着过度
, U9 K, l, {* R* xHypertension:高血压
) j# K4 Z5 W* R) {# lHypo- :(前缀)(过)低,少于1 @: o; S, s, K2 `6 c
Hypotension:低血压
1 S7 i1 Z7 [% u; S8 S: B# z( UIAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
3 r! m8 u! m: C" G3 I. y- Zid:medium dose,中剂量8 L% N4 M3 ?# V1 ?# I0 ?
id:initial dose,初始剂量
5 S$ Z4 c( m ~: I0 V5 |8 S& X2 HIF:involved field,累及野0 H; C5 c5 s. ~# U; K# p
IFN:interferon,干扰素2 H. \! T" Q, L
Ig:immunoglobulin,免疫球蛋白
/ e5 c j, \. m+ y% v+ F3 bIGFs: insulin-like growth factor,胰岛素样生长因子
0 s! n) }$ g+ B- R3 b: }IgH:immunoglobulin heavy chain,免疫球蛋白重链
, B) B' B% k1 Y' W+ uIL:interleukin,白细胞介素
% J& y5 k) z: ^! oIliac crest:髂嵴
9 G# ?6 D: ]: Z0 ZI.M.:intramuscular,肌肉注射
$ u( a% S8 z4 H. BImmune system:免疫系统 2 M- {2 g3 \% Y' U# |* x# Z
Immunocompromised:免疫受损的
4 C/ z% {' j( y; C- @! v) RImmunoglobulin:免疫球蛋白
& k& U9 L2 Y( @- Z$ m, U% uImmunological tolerance:免疫耐受
4 J+ O C) u8 |- h: Z' x) @Immunosuppression:免疫抑制 % L7 @3 o& i! m. _$ F
Incubation:孵育9 D( @7 I' s- {8 z- J
informed-consent:知情同意1 y A2 h) ^7 y5 M5 ?4 {6 f
Intravenous:静脉内的# d. K" T. [4 g/ M
inv: inversion,倒位
. N$ O. t# X; {- f7 B+ O7 Pin vitro: 体外,离体' n" Y/ @! I9 B1 Z' W$ T+ t
in vivo: 体内
9 ]& T, x, H2 H) R! \IP:interstitial pneumonia,间质性肺炎
1 N# j7 h9 B! @5 v# V$ g VIsolation: 分离
, I* a6 o; U- @9 w% b' LI.T.:intrathecal injection,鞘内注射
3 d d H5 r% Z; H o, q- t V-itis:(后缀)炎症 : s$ w% j! k% o6 j* k
ITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
v- x. F; j+ [ w! RJaundice:黄疸! \- ]( J6 X8 L
KPS:Karnofsky score, Karnofsky评分
8 w+ Y: }1 L+ r3 C8 SLAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
6 P# d: V* S" Z/ a# |# J0 qLaminar air flow unit:层流间 1 Q) A% e" k# h' U7 {
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症
7 l4 l, V V. v1 Z: f. oLD:lymphocyte depletion,淋巴细胞消减型
# M6 {9 E- g' d+ ^6 [1 CLD:low dose,小剂量
$ p% R6 L4 m0 vLDH:lactate dehydrogenase,乳酸脱氢酶
: M/ B4 V' H1 K3 h( Z- _7 u9 TLeukapheresis: 白细胞采集物- {3 {1 D2 m6 H# f0 Z3 k( v
Leukemia:白血病 - _4 S6 r4 v3 Z% \+ w
Leukocyte:白细胞
) R) X3 C1 ?' tLeukopenia: 白细胞减少症3 _& A$ u# {7 E z
LFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 , k d; g+ v ^. [6 @3 ?, q9 H
LFS:leukemia free survival,无白血病存活期4 B. `6 V/ B1 w9 |
LGL:low grade lymphoma,低度恶性淋巴瘤
* [3 {4 j7 z, F1 nLHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
8 C5 u0 g R6 c. ^6 {LI:labeling index,标记指数 e7 e( c+ D0 L0 c* }# K
LIF:leukemia inhibition factor,白血病抑制因子
: z1 _+ \2 C0 J0 gLineage:系9 X i. h7 D) o; S' z* f4 u
LOH:loss of heterozygosity,杂合性丢失( \9 e; N- }2 M/ L+ s
LP:lymphocyte predominance,淋巴细胞为主型; V7 Z. {' K' J0 [( `$ m
LRP:lung resistance related protein,肺抗性相关蛋白
0 ^: y7 u8 [ tLTB:life-threatening bleeding,致命性出血' _4 `/ Q- ?% c' C. {( o$ I
LTC-IC:long-term culture-initiating cell,长期培养起始细胞0 q( a8 m. v) r6 r
LTR:long terminal repeat:长末端重复序列
; f( D- ]& P: {- \LVL:large volume leukapheresis,大容量白细胞单采
$ n1 G3 m6 l% k& a" @) pLymphocyte: 淋巴细胞
/ L% a/ _8 T/ c2 I8 zMacrophage:巨噬细胞$ m |$ ?# s6 l, q0 O& K% y
MACS:magnetic activated cell sorting,磁性活化细胞分选
: J7 r: l8 {' E3 n, UMAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)
$ j4 R2 E" y4 d9 d; ]) KMalabsorption:吸收障碍5 C: n3 ], ~9 E/ {& \, R) Y K S; `
MALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷5 i* S L: s/ p! A9 b6 A3 r
Matching:配型
0 N1 C3 g) B4 A7 rMBDI:marrow blast decline index骨髓原始细胞减少指数
) h/ ?1 Z* I* u: gMC:mixed cellularity,混合细胞型; C. G# A; e! u. K& d; s
McAb:monoclonal antibody,单克隆抗体
* t/ L8 ^' H/ xmCR: median complete remission,中位完全缓解
/ ~8 w! p9 Q4 |8 D1 SMDR:multiple drug resistance,多药耐药0 h+ i7 \: d' i' i- d
MDS:myelodysplastic syndrome,骨髓增生异常综合征
2 Q; C" E. A+ q+ y0 }1 qMegakaryocyte:巨核细胞6 g& r K' s4 W; U: n9 H
Metabolite:代谢物 # n% s: o3 t2 N6 P1 F
Metastatic:转移的 4 p# j7 a( {- c5 n" X* \% W
MF:myelofibrosis,骨髓纤维化: f! X- P) o" p$ {% u8 K8 X& q8 R
MF:mycosis fungoides,蕈样霉菌病
4 _4 o$ a2 u2 z1 G6 wMGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子" i$ Z; k5 A" m t( d! V' |! F
MGP:marginal granulocyte pool,边缘粒细胞池6 v, `: \1 h6 X% V. Q9 R
MGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症
" y' C( f. _" g0 T, @, qMH:malignant histocytosis,恶性组织细胞增生症
! G2 ]4 U# a! j+ {7 J. [* cMHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
7 p/ s5 ^3 W; Q' G+ g9 i- l4 bMHC:major histocompatibility complex,主要组织相容性抗原复合体$ }. n' p4 Z" {2 X1 I/ l8 ?! I# ?
MLC:mixed lymphocyte culture,混合淋巴细胞培养 ) j0 m) _ z3 ]+ n$ r+ k7 T
MLL:mixed lineage leukemia,混合系白血病
{) S! j* r/ hMM:multiple myeloma,多发性骨髓瘤0 H) y S. v. ?& E9 }! s* n \$ t
MNC:mononuclear cells,单个核细胞
. v! p% l9 W/ K4 m* W( ]: RMobilization:动员
2 z# i0 w# v( d8 K) n3 x9 ?$ CMonoclonal antibody:单克隆抗体
' ^+ p/ g$ X W/ \6 k4 u6 tMonocyte:单核细胞 2 I4 v7 l `' r; Q
Monozygotic:单合子的" G( L6 [5 @ m& @- m
Morbidity:发病率 " j0 x6 z/ X& A! o7 E" R
MPD:myeloproliferative disease, 骨髓增殖性疾病
- l: s5 g* T; Q2 nMPO:myeloperoxidase,髓过氧化物酶
0 z. v9 {- V! X: BMRD:minimal residual disease,微小残留病变
4 U8 f- A0 x8 s2 w1 G7 D- {MRP:multidrug resistance-associated protein,多药耐药相关蛋白
( Q6 D0 g9 }, B) i; G$ AMucositis:粘膜炎 & R6 _ G7 A' r6 h
MUD:matched unrelated donor,非血缘关系配型相合供体7 e M4 \( t+ H( H/ |9 P' L
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶# v- K- N% y4 g0 f2 a
NB:neuroblastoma,神经母细胞瘤) f/ Y" v6 {% S4 R
NBM:normal bone marrow,正常骨髓
3 e8 ]/ ], R; l2 q# v9 }1 BNegative selection:阴性选择
% n" d* k; g3 Z) E( L1 |1 R/ sNeuro- :(前缀)神经的7 Y& k0 E- @) N; ^2 ^0 L0 | h
Neutropenia:中性粒细胞减少症 * W( c% _( Z. \1 q- P7 ~( t
Neutrophil:中性粒细胞 2 V( d1 O2 k, u5 T6 y- v" x& V
NG:neutrophil granulocyte,中性粒细胞
, j f2 c( p1 ?% k& K4 W' pNGF:nerve growth factor, 神经生长因子2 A5 L- [9 ]+ H! k- b6 i: ?
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
7 \2 L' ]! V- Y+ M, w. tNK: nature killer cell,自然杀伤细胞/ b" `6 a: [+ y D2 @
Nonmyeloablative transplantation: 非清髓性移植2 I6 F; c- U6 d* J& U
NPO:不能进食 ' F2 `4 z9 }1 t1 M" H/ z, P& G
NS:nodular sclerosis,结节硬化型 _: j) [$ T- O5 d3 J
Oncology:肿瘤学
! v$ A5 ]# B( C4 x$ {7 cOto- :(前缀)耳的
2 f. x0 G% t- [( fPA:plasminogen activator,纤溶酶原激活物% E+ V4 G9 b7 H& c
Packed red blood cells: 压积红细胞 4 B0 J2 {; e9 @2 ~
PAE:post antibiotic effects,抗生素后续作用+ c$ n& {! S R# O* [% N6 ]
PAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂6 {$ b! C: A# w8 c. G- _4 v' }
Palliative:减轻的,缓解的 0 n. i+ P7 k/ T) V4 }' I ^
palliative care unit (PCU):终末期病房,临终关怀病房$ s# |1 n* e% h8 {; P* O5 k( |5 G
Pancytopenia:全血细胞减少症
; _% }; }* Y0 K) L7 o- P! B& G-pathy:(后缀)病 - w: b) G3 D8 Q7 k7 F f H
PB:peripheral blood, 外周血) X7 v3 s* ?1 M% a D
PBL:peripheral blood lymphocyte,外周血淋巴细胞
; f2 z( o+ e( C% r$ U* @PBPC:peripheral blood progenitor cell,外周血祖细胞: v4 Q7 Z8 \6 X5 \
PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植7 G# u; ?$ S* T, i
PCA:procoagulant activity,促凝活性物质4 _5 k, _) e& |- ^, Z4 G
PCD:programmed cell death,细胞程序化死亡6 w/ o6 k9 G6 A$ ]
PCL:plasma cell leukemia,浆细胞白血病
/ w( f4 f' h7 Z6 A! ~PCLI:plasma cell label index,浆细胞标记指数/ X4 b" T" T0 ?$ m. j) f$ j
PCR:polymerase chain reaction, 多聚酶链反应
& T5 f- w" F) ]. S0 o8 |PCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
; E1 W$ y; u9 p! U7 f' Y7 ], n W) {) nPCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交/ @$ p o0 d* E
PDD:percentage depth dosage,百分深度剂量
; F& Y8 [% L9 N( z; u: ?PDGF:platelet derived growth factor,血小板衍生生长因子: R# c9 b& ]! e
PDR:primary drug resistance,原药耐药
2 {' k/ |3 c) s# ]PE:plasma exchange,血浆置换/ u: s4 q3 |" x7 ?4 \. Z; A4 e3 [
-penia:(后缀)缺乏,不足
* ?4 f& s& N% q! p! fPeripheral neuropathy:周围神经病变 . u" V" U" n7 C' j+ ^- r$ C% M/ I' b
Petechiae:瘀点,瘀斑
8 d O& X4 [! H& x( kPfu: plaque forming unit,空斑形成单位% R4 \1 _! S2 ^' T0 C _
PHA:phytahematoagglutinin,植物血凝素
x2 m2 J4 V" v( ]' T, i& nPhlebitis:静脉炎
+ z% a" Z/ J( F `! M/ X. uPHSC:pluripotential hematopoietic stem cell,多能造血干细胞9 U' e& A5 R( q' V
-plasia:(后缀)发展,形成 ' e3 f2 p6 T C' m
Plasma:血浆
" A2 H# R# ^6 S9 c/ fPlasma cell: 浆细胞 . I% S1 X- A; @
Platelet:血小板
5 j2 y1 D6 j. @" w ^PLG:plasminogen,纤溶酶原
+ ?- }* u" ] z$ lPLL:prolymphocytic leukemia,幼淋巴细胞白血病
: ^% i, u' g1 x, I( ~PLT:platelet,血小板0 u" @3 D2 X! j
PLT:primed lymphocyte test,预致敏淋巴细胞试验
' B3 ~# t) y; {/ @$ D4 t, U" J8 q$ nPMN:polymorphonuclear leukocyte,多形核白细胞
; K9 ?5 h% Y$ z; X" V8 Y! l, Z" yPNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷3 A# F; K. @ C* W3 u; z
PNRE:p53 negative response element,p53阴性反应元件
# B$ T& G$ w ~3 RPOD:PML oncogenic domain,PML癌基因结构域; @9 z; g6 X7 G! i" A# d! _* \& E9 d
Polycythemia:红细胞增多症
3 s% ~! Q) N% x/ _Positive selection:阳性选择+ y: K2 S( T# u4 X1 p3 g0 D4 n
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞
. I0 ]7 f3 ~+ EPreparative regimen:预处理方案 # c. O, M- ^0 Z7 P5 t
Progenitor:前体,祖先
# f! z) ~- m. m' D! u, h9 G: x! _Prognosis:预后
8 u' a$ ^/ W9 OProphylactic:adj.预防的;n. 预防性,预防药
5 s3 o" p1 n hProphylaxis:预防法,预防. l- L1 n+ J' V B$ E+ q
Protocol:草案,协议,治疗方案
7 q( c3 i4 v, s. q- WProto-onc: proto-oncogene,原癌基因. J; z9 P- B! o$ _5 \* l4 C, Z
PSS:posterior superior spine,髂后上棘
6 g# }" h2 Q% H1 `7 n2 W G- fPT:prothrombin time,凝血酶原时间: ]% ^- K2 j; M
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤 R! Z# z: E X7 Z6 F8 w
PTH:post-transfusion hepatitis, 输血后肝炎
/ w9 U5 [3 p7 F7 \: ]Pulmonary:肺的
$ D2 z9 P- W/ @, aPurging:净化
) f$ s- W$ H$ Q: {) `) {$ V; V# sPurity:纯度
# j4 y% ~9 T+ q" ^PV:polycythemia vera,真性红细胞增多症& ?/ {. J: G) A( H" w# @' ]" _
Quality of Life (QOL):生活质量
/ z' _ O: ]- {1 dRA:refractory anemia,难治性贫血
* i7 j" v# l. IRAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型7 J2 d! ]+ q( x* b! c8 a0 ?
RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型1 N1 q8 m4 o3 m/ c1 d" X
RAR:retinoic acid receptor,维甲酸受体: K. d& F/ t2 m6 h6 k L( ]
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多, S2 g3 I: w: Q/ V7 M7 Y
RAS:retinoic acid syndrome,维甲酸综合征
. j8 x) F1 N7 Q# g. o; M1 [5 ZRB:retinoblastoma,视网膜母细胞瘤3 a2 a: S! D$ r9 |
RBC: red blood cell,红细胞 # _; Z+ B7 }; x9 Y. x
Reagent:试剂% A% t4 v& h t( `$ ] A
Recipient:受者 ! a+ v& H4 h' Z: w4 L
Rejection:排斥
* u+ P. @6 w' f/ v* W2 ~Relapse:复发 5 s) E; x$ k& {5 L
Remission:缓解 : }/ ^; z- H) h. @
Renal:肾脏的,肾的 6 V" H# ~0 Y/ p {9 m& L
RFS:replase free survival,无复发生存+ R U$ T' |; s, Z( b
RPC:radiation protective competence, 辐射保护能力
( ^% Z3 p' A, ]5 ?( P3 X3 c u$ \& PRegimen-related toxicity (RRT):预处理相关毒性& C9 H' u8 ~. W3 u4 A
RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应# |& `# i% g! z8 `- I% h. ]
SBB:sudan black B,苏丹黑B
1 @% W* R0 U. P9 g- Q) S. G- \SCE:sister chromatial exchange,姐妹染色单体交换
3 ^8 P {4 `% ~% dSCF:stem cell factor,干细胞因子
- z. n/ {* J6 E7 hSCid:severe combined immunodeficiency disease,重症联合免疫缺陷 ^) g; ~$ T' |" `! W. v' A9 _
SCL:stem cell leukemia,干细胞白血病
5 s, X& @% V% n0 I# p3 A. o: LSE:specific estarase,特异性酯酶) ~ M! R2 k: H: r% U3 C& s
Selectin:选择素
8 c. P. P' q w4 C* h( `Sense primer:同义引物
8 N( v- b! [. M# _+ BSeparation:(细胞)分选4 ?$ ?# P) d0 B0 v3 U& u7 }
Sepsis:脓血病,败血病 ' S) j( }5 T; n9 ^5 P* \
Sequencing测序
5 E N( g( m7 ASF:serum ferritin,血清铁蛋白
: X4 q5 a# M8 @9 CSHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大1 W& r1 T% T2 W9 C; i
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法4 R5 E, a: l8 P9 W
SLE:systemic lupus erythematosus,系统性红斑狼疮
4 @7 H$ v& X7 x* rSLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤- V: x9 u- H% c* n& ?* {% p0 R" g( c
Solid tumor:实体瘤 N! t/ u! p6 l" B M- _6 G# ?: y
SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病
" {9 m4 g7 }- w2 F; P( y0 eSRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞
+ m' s, v6 a6 ?SS:Sezary syndrome,Sezary综合征
$ C9 P. m, {' T8 h7 fStem cell:干细胞" p! }) G6 I+ ? U6 J# S" H( v6 ^
STNI:subtotal nodal irradiation,次全淋巴结照射 8 [+ O l9 o" y; U$ \* W! D
Stomatitis:口炎 8 K: a6 z8 |9 C* O
Subclavian catheter:锁骨下导管 1 }* w) y( T' d1 u$ g
Supernatant:上清
& _$ }0 X* X/ p7 @Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植 5 [" i, r% \ Q- a& d
Syngeneic:同基因的
/ L- Y3 f% S6 ^4 R) M& iTAM:tumor associated macrophage,肿瘤相关巨噬细胞 a8 N3 a c8 `/ h4 g
t-AML:treatment associated AML,治疗相关的急性髓性白血病
9 g: }& Z0 z; n7 B% W+ k+ XTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病
' {7 R7 i5 c! r$ N* |4 X8 ?TAA:tumor associated antigen,肿瘤相关抗原7 A) ?; u8 X$ R- H1 L& n/ N
TBGP:total blood granulocyte pool,总血液粒细胞池: k9 t6 u9 q$ E. Q5 g/ }* K7 f( p4 l
TBI:total body irradiation,全身照射
, Q% s+ w3 M0 `3 i, J" C0 XTc:time of cell cycle, 细胞周期时间
! d( Q5 Q* A0 ~$ P+ P; ]% I N: X( CTCD:T cell depletion, T细胞去除
% d& _: t, q! m( h4 T+ DTCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤
7 P& I4 j& M, _: YTCR:T cell receptor,T细胞受体
: ]! \9 y1 W% T1 GTCS:tumor cell survival,肿瘤细胞成活7 j' ~) _9 X$ v. H5 `
TEN:total enteral nutrition,完全胃肠内营养5 r4 }0 e+ @0 W) ]# Y" @+ n
TF:tissue factor,组织因子
. m7 Q4 k! v: A/ ]+ d$ oTF:thymic factor,胸腺因子. Q. j$ B+ j7 W3 [6 O
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物4 t+ V, R3 e0 H. h
TGF:therapeutic gain factor,治疗获得系数
9 C# t n% p b/ C* T$ I- NTGF-β:transforming growth factor-β,转化生长因子β
8 M- M+ j- L" b- w& n& y @Thrombocyte:血小板 ' H' V% S, [2 `- t( a
Thrombocytopenia:血小板减少症5 s9 a' c9 W2 @9 c: }, [
TIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞- h2 D7 C$ N1 ]; g Z/ m* X" E* e
TL:testis leukemia睾丸白血病
* S1 e5 Y" q; s8 O8 X4 oTLI:total Lymphoid irradiation,全淋巴照射9 t8 g2 s) ]8 o4 J4 A1 b" k
Thrombotic microangiopathy (TMA):血栓性微血管病
6 F+ f7 U/ b0 V- x5 y0 C7 tTNF:tumor necrosis factor,肿瘤坏死因子6 Z' m( n+ ^7 X9 |* a; T6 Y
TNI:total nodal irradiation,全淋巴结照射( y. N% \% U. V* ~+ q: t% S
TOPO II:topoisomerase II,拓扑易构酶II
8 V0 i- f. W( JToxin:毒素
5 ~# |, y- b0 w5 W, z6 l- GTpdt:potential doubling time,倍增时间/ E6 [* ^8 {. X7 e
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病0 y+ `& u6 ]% n3 x. d/ Z
TPN:total parenteral nutrition,全肠道外营养,静脉高营养
1 K% n" t+ V1 v7 `/ d1 OTPO:thrombopoietin,促血小板生成素* ], Q3 f1 O/ u! o4 k6 f0 c
TPS:treatment planning system,治疗计划系统- F" @! N# ~% o' P9 Q9 n" K
Translocation:易位3 _, c* {1 b3 U Z
Trauma:创伤
. B- _. f. q* C$ H: b- r* ETRM:transplantation related mortality,移植相关死亡率, w9 c: b; g* l8 n( V2 `
TSC:timed-sequential chemotherapy,时相序贯化疗6 Z2 F+ m, ~0 d6 g$ c
TSPA:triophosphoramide,噻替派
* d# {; \( ?. wTTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜% k) F7 y$ T, n' o( b* @
Tumor:肿瘤
3 I! W% A8 E. s7 s% P/ jTumor burden:肿瘤负荷 ' g/ f7 C, g) q( s: X
UCB:umbilical cord blood,脐带血
5 X. _5 w w( d% ^# AUltrasound:超声 ; B0 v6 j) b8 E3 g5 J2 v7 q
Umbilical cord:脐带% m4 v) G t8 R3 @% p R% r E
VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征) g% W5 T6 e+ B& h
VGPR:very good partial remission,非常良好的部分缓解
( Q3 X9 r9 E, VViability:活性4 O5 d8 u8 b9 \$ B2 @% i: N
Virus:病毒 & J2 R+ b' \5 W; R- A
VOD:veno-occlusive disease,静脉阻塞性疾病
, g* v6 G- I3 Z, hv-onc: virus oncogene,病毒癌基因
7 U0 a' X q0 \5 ?6 Y1 T& WVPF: vascular permeability factor,血管渗透因子# E, e( t! j" I( l' f* r1 Z
VZV:varicella zoster virus,水痘带状疱疹病毒
* H2 G; R; ~, q) HWBC:white blood cell,白细胞 " ^$ p. S! v, z: r: r" n
Whole blood:全血
. B- s- X. T; J8 }* r( ]5 `8 PWT:Wilms tumor,肾母细胞瘤9 Q5 ?7 j, p, _! N& }! b
Xerostomia:口腔干燥症 8 }7 t6 a2 K3 W3 M4 W; a
Yield:产量 |
|